Novo Nordisk's Stock Split Boosts Liquidity and Market Performance

1 min read
Source: Yahoo Finance
TL;DR Summary

Novo, the maker of Ozempic, experienced a drop in its stock price after its first stock split in a decade.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

0 min

vs 1 min read

Condensed

73%

7520 words

Want the full story? Read the original article

Read on Yahoo Finance